참고문헌
- Katherine T, John D, Fotis I et al : Management of adenoid cystic carcinoma of minor salivary glands. J Oral Maxillofac Surg 64 : 1114, 2006 https://doi.org/10.1016/j.joms.2005.06.017
- Fan X, Yincheng Z, Feng L et al : Expression of IgSF in salivery adenoid cystic carcinoma and its relationship with invasion and metastasis. J Oral Patho Med 34 : 295, 2005 https://doi.org/10.1111/j.1600-0714.2005.00312.x
- Alfro JT, Andre DN, Priscila PCA et al : Management of salivary gland adenoid cystic carcinoma: institutional experience of a case series. Sao Paulo Med J 124(1) : 26, 2006 https://doi.org/10.1590/S1516-31802006000100006
- Son CW, Kim KW, Kim CH : Study on Expression of glycosaminoglycan in adenoid cystic carcinoma. J Kor Oral Maxillofac Surg 30 : 271, 2004
- Park YW : Celluar and molecular characterization of adenoid cyctic carcinoma of the salivary glands. J Kor Assoc Of Maxillofac Plast And Reconstr Surg 27(2) : 110, 2005
- Raguse JD, Gath HJ, Bier J et al : Docetaxel (taxotere) in recurrent high grade mucoepidermoid carnicoma of the major salivary glands. Oral Oncology EXTRA 40 : 5, 2004 https://doi.org/10.1016/S1741-9409(03)00003-7
- Bell BR, Dierks EJ, Homer L et al : Management and outmoce of patients with malignant salivary gland tumors. J Oral Maxillofac Surg 63 : 917, 2005 https://doi.org/10.1016/j.joms.2005.03.006
- Yih WY, Kratochvil EJ, Stewart CB : Intraoral minor salivary gland neoplasms: review of 213 cases. J Oral Maxillofac Surg 63 : 805, 2005 https://doi.org/10.1016/j.joms.2005.02.021
- Bhattacharyya N : Survival and prognosis for cancer of the submandibular gland. J Oral Maxillofac Surg 62 : 427, 2004 https://doi.org/10.1016/j.joms.2003.06.012
- Perez DEC, Pires FR, Lopes MA et al : Adenoid cystic carcinoma and mucoepidermoid carcinoma of the maxillary sinus: report of a 44-year experience of 25 cases from a single institution. J Oral Maxillofac Surg 64 : 1592, 2006 https://doi.org/10.1016/j.joms.2005.11.088
- Baj A, Bertolini F, Ferrari S et al : Central mucoepidermoid carcinoma of the jaw in a teenager: a case report. J Oral Maxillofac Surg 60 : 207, 2002 https://doi.org/10.1053/joms.2002.29827
- Sidoni A, Derrico P, Simoncelli C et al : Central mucoepidermoid carcinoma of the mandible: report of a case treated 13 years after first radiographic demonstration. J Oral Maxillofac Surg 54 : 1242, 1996 https://doi.org/10.1016/S0278-2391(96)90361-4
- Ishibashi H, Shiratuchi T, Nakagawa K et al : Hypoxiainduced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral Oncol 37 : 77, 2001 https://doi.org/10.1016/S1368-8375(00)00062-2
- Weal S, Hiroko IY, Takashi S : Angiogenesis in mucous retention cyst: a human in vivo-like model of endothelial cell differentiation in mucous substrate. J Oral Pathol Med 34 : 30, 2005 https://doi.org/10.1111/j.1600-0714.2004.00282.x
- Lim JJ, Kang SM, Lee MR et al : Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med 32 : 552, 2003 https://doi.org/10.1034/j.1600-0714.2003.00145.x
- Peter AB, Tijjani U, Alan WW et al : Expression of type 2 nitric oxide synthase and vascular endothelial growth factor in oral dysplasia. J Oral Maxillofac Surg 60 : 1455, 2002 https://doi.org/10.1053/joms.2002.36122
- Shang ZJ, Li JR, Li ZB : Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma. J Oral Maxillofac Surg 65 : 17, 2007
- Wong YK, Liu CJ, Kwan PC et al : Microvascular density and vascular endothelial growth factor immunoreactivity as predictors of regional lymph node metastasis from betelassociated oral squamous cell carcinoma. J Oral Maxillofac Surg 61 : 1257, 2003 https://doi.org/10.1016/S0278-2391(03)00725-0
- Schmugge M, Rand ML, Freedman J : Platelets and von willebrand factor. Transfusion and Apheresis Science 28 : 269, 2003 https://doi.org/10.1016/S1473-0502(03)00046-6
- Shavit JA, Motto DG : Coagulation and metastasis - an unexpected role for von Villebrand factor. J Thromb Heamost 4 : 517, 2006 https://doi.org/10.1111/j.1538-7836.2006.01805.x
- Paczuski R, Bialkowska A, Kotschy M et al : Von villebrand factor in plasma of patients with advanced stages of larynx cancer. Thrombosis Research 95 : 197, 1999 https://doi.org/10.1016/S0049-3848(99)00041-9
- Zavero MR : Structure of von villebrand factor and its function in platelet adhesion and thrombus formation. Best Practice & Research Clinical Heamatology 14(2) : 257, 2001 https://doi.org/10.1053/beha.2001.0133
- Teo NB, Shoker BS, Jarvis C et al : Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast. European Journal of Cancer 39 : 38, 2003 https://doi.org/10.1016/S0959-8049(02)00248-4
- Kikaku G : Immunohistochemistry. Gakusai Kikaku Co, 2002, p.297
- Lee SK, Kim YS, Song IS et al : Improved technique of digoxigenin labeled RNA in situ hybridization. The Korean Journal of Pathology 35 : 98, 2001
- Bhat TA, Singh RP : Tumor angiogenesis - a potential target in cancer chemoprevention. Food Chem Toxicol : 1, 2007
- Pang R, Poon RPT : Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Letters 242 : 151, 2006 https://doi.org/10.1016/j.canlet.2006.01.008
- Schmidt M, Lichtner RB : EGF receptor targeting in therapy-resistant human tumors. Drug Resistance Updates 5 : 11, 2002 https://doi.org/10.1016/S1368-7646(02)00004-3
- Yao JC : Molecular targeted therapy for carcinoid and islet-cell carcinoma. Best Practice & Research Clinical Endocrinology & Metabolism 21 : 163, 2007 https://doi.org/10.1016/j.beem.2007.01.006
- Park YW : Cellular and molecular characterization of adenoid cystic carcinoma of the salivary glands. J Kor Acad Maxillofac Plast Reconst Surg 27(2) : 110, 2005
- Park YW, In YS : Immunohistochemical assays for the expression of angiogenic signaling molecules and microvessel density in adenoid cystic carcinomas of human salivary glands. J Kor Assoc Oral Maxillofac Surg 32(6) : 530, 2006
- In YS, Kim SM, Park YW : Comparative immunohistochemical assays for the expression of angiogenic factors in tumors of human salivary glands. J Kor Acad Maxillofac Plast Reconst Surg 29(1) : 10, 2007
- Jang JH, Kwon KJ, Park YW : Expressions of vascular metastasis related actors in murine orthotopic tumor models of salivary glands. J Kor Acad axillofac Plast Reconst Surg 29(6) : 499, 2007
- Beltran D, Faquin WC, Gallagher G et al : Selective immunohistochemical comparison of polymorphous lowgrade adenocarcinoma and adenoid cystic carcinoma. J Oral Maxillofac Surg 64 : 415, 2006 https://doi.org/10.1016/j.joms.2005.11.027
- Hartenbach EM, Olson TA, Moganraj GD et al : Vascular endothelial growth factor(VEGF) expression and survival in human epithelial ovarian carcinomas. Cancer Letters 121 : 169, 1997 https://doi.org/10.1016/S0304-3835(97)00350-9
- Ribatti D, Cruz A, Nico B et al : in situ hybridization and immunogold localization of vascular endothelial growth factor receptor-2 on the pericytes of the chick chorioallantoic membrane. Elsevier Science Ltd 17(5) : 262, 2002 https://doi.org/10.1006/cyto.2002.1002
- Fukuzawa M, Sugiura H, Koshinaga T et al : Expression of vascular endothelial growth factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization. Journal of Pediatric Surgery 37(12) : 1747, 2002 https://doi.org/10.1053/jpsu.2002.36712
- Blot E, Decaudin D, Veyradier A et al : Cancer-related thrombotic microangiopathy secondary to von vellibrand factor-cleaving protease dificiency. Thrombosis Research 106 : 127, 2002 https://doi.org/10.1016/S0049-3848(02)00095-6
- Morganti M, Mittermayer C, Hanze U et al : Expression of tissue-type plasminogen activator, plasminogen activator inhibitor and von willebrand factor in the supernatant of endothelial cell cultures in response to the seeding of adenocarcinoma cell line HRT-18. Biomed & Pharmacother 50 : 373, 1996 https://doi.org/10.1016/S0753-3322(96)89671-5
- Morganti M, Carpi A, Amo-Takyi B et al : Von Villebrand's factor mediates the adherence of human tumoral cells to human endothelial cells and ticlopidine interferes with this effect. Biomed & Pharmacother 54 : 431, 2000 https://doi.org/10.1016/S0753-3322(00)00006-8
- Davies DE, Chamberlin SG : Targeting the epidermal growth factor receptor for therapy of carcinomas. Biochemical Pharmacology 51 : 1101, 1996 https://doi.org/10.1016/0006-2952(95)02232-5
- Gao ZN, Wei YQ, Yang PS et al : Combined effects of soluble vascular endothelial growth factor receptor FLT-1 gene therapy and cisplantin chemotherapy in human tongue carcinoma xenografts. Oral Oncology 43 : 477, 2007 https://doi.org/10.1016/j.oraloncology.2006.05.009